US4605661A
(en)
*
|
1984-06-18 |
1986-08-12 |
Eli Lilly And Company |
Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
|
EP0225292A3
(en)
|
1985-12-06 |
1988-11-30 |
Ciba-Geigy Ag |
Certain n-substituted butyramide derivatives
|
DE3811574A1
(de)
*
|
1988-03-31 |
1989-10-19 |
Schering Ag |
N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
|
DE4138042C2
(de)
|
1991-11-19 |
1993-10-14 |
Biotechnolog Forschung Gmbh |
Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel
|
US20030203976A1
(en)
|
1993-07-19 |
2003-10-30 |
William L. Hunter |
Anti-angiogenic compositions and methods of use
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
KR101222904B1
(ko)
|
1993-07-19 |
2013-01-17 |
안지오테크 파마슈티칼즈, 인코포레이티드 |
항맥관형성 조성물, 당해 조성물로 피복된 스텐트 및 당해 스텐트의 제조방법
|
ES2178093T5
(es)
|
1995-11-17 |
2009-02-16 |
Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf) |
Derivados de epotilon y su preparacion.
|
DE19607702A1
(de)
|
1996-02-29 |
1997-09-04 |
Biotechnolog Forschung Gmbh |
Heterozyklische Verbindungen, Herstellungsverfahren und Mittel
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
HU226646B1
(en)
|
1996-03-12 |
2009-05-28 |
Pg Txl Company |
Water soluble pharmaceutical compositions containing taxane derivatives
|
US20040106985A1
(en)
|
1996-04-26 |
2004-06-03 |
Jang G. David |
Intravascular stent
|
US5917084A
(en)
|
1996-07-03 |
1999-06-29 |
Millennium Pharmaceuticals, Inc. |
Antifungal agents
|
DE19645362A1
(de)
|
1996-10-28 |
1998-04-30 |
Ciba Geigy Ag |
Verfahren zur Herstellung von Epothilon A und B und Derivaten
|
DE19645361A1
(de)
|
1996-08-30 |
1998-04-30 |
Ciba Geigy Ag |
Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B, Teil II
|
DE19636343C1
(de)
|
1996-08-30 |
1997-10-23 |
Schering Ag |
Zwischenprodukte innerhalb der Totalsynthese von Epothilon A und B
|
US5969145A
(en)
|
1996-08-30 |
1999-10-19 |
Novartis Ag |
Process for the production of epothilones and intermediate products within the process
|
DE19638870B4
(de)
|
1996-09-23 |
2009-05-14 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Tubulysine, Verfahren zu ihrer Gewinnung und sie enthaltende Mittel
|
PT941227E
(pt)
*
|
1996-11-18 |
2004-08-31 |
Biotechnolog Forschung Mbh Gbf |
Epothilona d sua preparacao e sua utilizacao como agente citostatico ou como agente de proteccao fitossanitaria
|
US6204388B1
(en)
|
1996-12-03 |
2001-03-20 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6867305B2
(en)
*
|
1996-12-03 |
2005-03-15 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
JP4579351B2
(ja)
|
1996-12-03 |
2010-11-10 |
スローン−ケッタリング インスティトュート フォア キャンサー リサーチ |
エポチロンの合成とその中間体及びその類似物並びにその使用
|
US6660758B1
(en)
|
1996-12-13 |
2003-12-09 |
The Scripps Research Institute |
Epothilone analogs
|
US6380394B1
(en)
|
1996-12-13 |
2002-04-30 |
The Scripps Research Institute |
Epothilone analogs
|
DE19701758A1
(de)
|
1997-01-20 |
1998-07-23 |
Wessjohann Ludgar A Dr |
Epothilone-Synthesebausteine
|
CN1128803C
(zh)
|
1997-02-25 |
2003-11-26 |
生物技术研究有限公司(Gbf) |
环氧噻嗪酮b-n-氧化物及其制备方法
|
US20020086812A1
(en)
|
1997-03-04 |
2002-07-04 |
Schweinfest Clifford W. |
Methods and compositions for diagnosis and treatment of cancer
|
DE19713970B4
(de)
|
1997-04-04 |
2006-08-31 |
R&D-Biopharmaceuticals Gmbh |
Epothilone-Synthesebausteine II - Prenylderivate
|
ATE225783T1
(de)
|
1997-04-18 |
2002-10-15 |
Studiengesellschaft Kohle Mbh |
Selektive olefinmetathese von bi- oder polyfunktionellen substraten in komprimiertem kohlendioxid als reaktionsmedium
|
US6117659A
(en)
|
1997-04-30 |
2000-09-12 |
Kosan Biosciences, Inc. |
Recombinant narbonolide polyketide synthase
|
DE19849464A1
(de)
|
1997-04-30 |
2000-04-27 |
Schering Ag |
Wirkstofffreisetzende Stents, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
DE19720312A1
(de)
|
1997-05-15 |
1998-11-19 |
Hoechst Ag |
Zubereitung mit erhöhter in vivo Verträglichkeit
|
DE19821954A1
(de)
|
1997-05-15 |
1998-11-19 |
Biotechnolog Forschung Gmbh |
Verfahren zur Herstellung eines Epothilon-Derivats
|
US20030049841A1
(en)
|
1997-06-16 |
2003-03-13 |
Short Jay M. |
High throughput or capillary-based screening for a bioactivity or biomolecule
|
DE19726627A1
(de)
|
1997-06-17 |
1998-12-24 |
Schering Ag |
Zwischenprodukte, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Epothilon
|
US6605599B1
(en)
*
|
1997-07-08 |
2003-08-12 |
Bristol-Myers Squibb Company |
Epothilone derivatives
|
JP2001510189A
(ja)
|
1997-07-16 |
2001-07-31 |
シエーリング アクチエンゲゼルシヤフト |
チアゾール誘導体、その製造法および使用
|
DE19735578A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue (C1-C6)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
JP2001512723A
(ja)
|
1997-08-09 |
2001-08-28 |
シエーリング アクチエンゲゼルシヤフト |
新規エポチロン誘導体、その製法およびその薬学的使用
|
DE19751200A1
(de)
|
1997-11-13 |
1999-05-20 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19735575A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue (C13-C15)-Fragmente, Verfahren zur Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
DE19735574A1
(de)
|
1997-08-09 |
1999-02-11 |
Schering Ag |
Neue [C1(Carboxa)-C6]-Fragmente, Verfahren zu ihrer Herstellung und ihre Verwendung zur Synthese von Epothilon und Epothilonderivaten
|
DE19813821A1
(de)
|
1998-03-20 |
1999-09-23 |
Schering Ag |
Verfahren zur Herstellung von C1-C6-Bausteinen zur Totalsynthese von Epothilon und Epothilon-Derivaten
|
DE19749717A1
(de)
|
1997-10-31 |
1999-05-06 |
Schering Ag |
Neue C1-C6-Bausteine zur Totalsynthese neuer Epothilon-Derivate sowie Verfahren zur Herstellung dieser Bausteine
|
DE19744135C1
(de)
|
1997-09-29 |
1999-03-25 |
Schering Ag |
Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
|
US6365749B1
(en)
|
1997-12-04 |
2002-04-02 |
Bristol-Myers Squibb Company |
Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
|
US6320045B1
(en)
|
1997-12-04 |
2001-11-20 |
Bristol-Myers Squibb Company |
Process for the reduction of oxiranyl epothilones to olefinic epothilones
|
US6096757A
(en)
|
1998-12-21 |
2000-08-01 |
Schering Corporation |
Method for treating proliferative diseases
|
US6280999B1
(en)
|
1998-01-23 |
2001-08-28 |
Kosan Bioscience |
Sorangium polyketide synthases and encoding DNA therefor
|
US6090601A
(en)
|
1998-01-23 |
2000-07-18 |
Kosan Bioscience |
Sorangium polyketide synthase
|
US6683100B2
(en)
|
1999-01-19 |
2004-01-27 |
Novartis Ag |
Organic compounds
|
MY125921A
(en)
|
1998-02-05 |
2006-08-30 |
Novartis Ag |
Compositions containing organic compounds
|
DE19804673A1
(de)
|
1998-02-06 |
1999-08-12 |
Studiengesellschaft Kohle Mbh |
Verfahren zur Darstellung makrocyclischer Produkte durch ringschliessende Diin-Metathese
|
US6194181B1
(en)
|
1998-02-19 |
2001-02-27 |
Novartis Ag |
Fermentative preparation process for and crystal forms of cytostatics
|
FR2775187B1
(fr)
|
1998-02-25 |
2003-02-21 |
Novartis Ag |
Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
|
US6302838B1
(en)
|
1998-02-25 |
2001-10-16 |
Novartis Ag |
Cancer treatment with epothilones
|
MXPA00008365A
(es)
|
1998-02-25 |
2002-11-07 |
Sloan Kettering Inst Cancer |
Sintesis de epotilonas, intermediarios y analogos de las mismas.
|
US6399638B1
(en)
|
1998-04-21 |
2002-06-04 |
Bristol-Myers Squibb Company |
12,13-modified epothilone derivatives
|
US6407103B2
(en)
|
1998-04-21 |
2002-06-18 |
Bristol-Myers Squibb Pharma Company |
Indeno [1,2-c] pyrazol-4-ones and their uses
|
US6498257B1
(en)
|
1998-04-21 |
2002-12-24 |
Bristol-Myers Squibb Company |
2,3-olefinic epothilone derivatives
|
JPH11322611A
(ja)
*
|
1998-05-14 |
1999-11-24 |
Sankyo Co Ltd |
抗ウイルス剤
|
GB9810659D0
(en)
|
1998-05-18 |
1998-07-15 |
Ciba Geigy Ag |
Organic compounds
|
DE19826988A1
(de)
|
1998-06-18 |
1999-12-23 |
Biotechnolog Forschung Gmbh |
Epothilon-Nebenkomponenten
|
US6121029A
(en)
|
1998-06-18 |
2000-09-19 |
Novartis Ag |
Genes for the biosynthesis of epothilones
|
DE19923001A1
(de)
|
1999-05-13 |
2000-11-16 |
Schering Ag |
Epothilon-Derivate, Verfahren zu deren Herstellung, Zwischenprodukte und ihre pharmazeutische Verwendung
|
DE19830060A1
(de)
|
1998-06-30 |
2000-02-10 |
Schering Ag |
Epothilon-Derivate, Verfahren zu deren Herstellung, Zwischenprodukte und ihre pharmazeutische Verwendung
|
WO2000001838A2
(en)
|
1998-07-02 |
2000-01-13 |
The Board Of Regents Of The Leland Stanford Junior University |
Methods for making polyketides
|
US20030199535A1
(en)
|
1998-07-30 |
2003-10-23 |
Claudio Cavazza |
Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent
|
DE69934242T2
(de)
|
1998-10-02 |
2007-09-20 |
Kosan Biosciences, Inc., Hayward |
Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
|
DE19846493A1
(de)
|
1998-10-09 |
2000-04-13 |
Biotechnolog Forschung Gmbh |
DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
|
DE19848306A1
(de)
|
1998-10-14 |
2000-04-20 |
Schering Ag |
Verfahren zur Herstellung von Epothilon B und Derivaten sowie Zwischenprodukte für dieses Verfahren
|
JP2003512013A
(ja)
|
1998-10-29 |
2003-04-02 |
コーサン バイオサイエンシーズ, インコーポレイテッド |
組換えオレアンドライドポリケチドシンターゼ
|
US6303767B1
(en)
|
1998-11-05 |
2001-10-16 |
Kosan Biosciences, Inc. |
Nucleic acids encoding narbonolide polyketide synthase enzymes from streptomyces narbonensis
|
US6410301B1
(en)
|
1998-11-20 |
2002-06-25 |
Kosan Biosciences, Inc. |
Myxococcus host cells for the production of epothilones
|
NZ511722A
(en)
|
1998-11-20 |
2004-05-28 |
Kosan Biosciences Inc |
Recombinant methods and materials for producing epothilone and epothilone derivatives
|
JP2002533346A
(ja)
|
1998-12-22 |
2002-10-08 |
ノバルティス アクチエンゲゼルシャフト |
エポシロン誘導体およびそれらの抗腫瘍剤としての使用
|
US6780620B1
(en)
|
1998-12-23 |
2004-08-24 |
Bristol-Myers Squibb Company |
Microbial transformation method for the preparation of an epothilone
|
US6419692B1
(en)
|
1999-02-03 |
2002-07-16 |
Scimed Life Systems, Inc. |
Surface protection method for stents and balloon catheters for drug delivery
|
US6596875B2
(en)
*
|
2000-02-07 |
2003-07-22 |
James David White |
Method for synthesizing epothilones and epothilone analogs
|
JP2002537262A
(ja)
|
1999-02-18 |
2002-11-05 |
オキシジェン,インコーポレイティド |
血管破壊のターゲッティングに使用するための組成物および方法
|
DE19908767A1
(de)
|
1999-02-18 |
2000-10-19 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
US6406722B1
(en)
|
1999-02-18 |
2002-06-18 |
Robert G. Gallaher |
Method of treating viral infections and lesions with taxane compounds
|
EE200100431A
(et)
|
1999-02-18 |
2002-12-16 |
Schering Aktiengesellschaft |
16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
|
DE19908765A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
16-Halogen-Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19908760A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19954230A1
(de)
|
1999-11-04 |
2001-11-15 |
Schering Ag |
16-Halogen-Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE19908763A1
(de)
|
1999-02-18 |
2000-08-24 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
US6262094B1
(en)
|
1999-02-22 |
2001-07-17 |
Bristol-Myers Squibb Company |
C-21 modified epothilones
|
DE19907588A1
(de)
|
1999-02-22 |
2000-08-24 |
Biotechnolog Forschung Gmbh |
C-21 Modifizierte Epothilone
|
DE19930111A1
(de)
|
1999-07-01 |
2001-01-04 |
Biotechnolog Forschung Gmbh |
C-21 Modifizierte Epothilone
|
US20020058286A1
(en)
|
1999-02-24 |
2002-05-16 |
Danishefsky Samuel J. |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6291684B1
(en)
|
1999-03-29 |
2001-09-18 |
Bristol-Myers Squibb Company |
Process for the preparation of aziridinyl epothilones from oxiranyl epothilones
|
US6211412B1
(en)
|
1999-03-29 |
2001-04-03 |
The University Of Kansas |
Synthesis of epothilones
|
US6603015B2
(en)
|
1999-03-29 |
2003-08-05 |
University Of Kansas |
Synthesis of epothilones
|
US6514330B1
(en)
|
1999-04-06 |
2003-02-04 |
Seiko Epson Corporation |
Ink composition containing copper complex colorant
|
JP2002541200A
(ja)
|
1999-04-14 |
2002-12-03 |
デイナ−ファーバー キャンサー インスティチュート,インコーポレイテッド |
癌の処置のための方法および組成物
|
US7125875B2
(en)
|
1999-04-15 |
2006-10-24 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
RU2260592C9
(ru)
|
1999-04-15 |
2017-04-07 |
Бристол-Маерс Сквибб Ко. |
Циклические ингибиторы протеинтирозинкиназ
|
DE10015836A1
(de)
|
2000-03-27 |
2001-10-11 |
Schering Ag |
6-Alkenyl- und 6-Alkinyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
DE19954228A1
(de)
|
1999-11-04 |
2001-09-13 |
Schering Ag |
6-Alkenyl-und 6-Alkinyl-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
JP4707240B2
(ja)
*
|
1999-05-05 |
2011-06-22 |
アベンティス・フアーマ・リミテッド |
細胞接着調節剤としての尿素
|
KR100621185B1
(ko)
|
1999-09-09 |
2006-09-06 |
삼성전자주식회사 |
디디씨 모니터의 동작 기록형 마이크로컴퓨터의 제어방법
|
US6569867B2
(en)
|
1999-10-01 |
2003-05-27 |
Kosan Biosciences, Inc. |
Polyketide derivatives
|
US20020147197A1
(en)
|
1999-10-08 |
2002-10-10 |
Newman Michael J. |
Methods and compositions for enhancing pharmaceutical treatments
|
US20030054977A1
(en)
|
1999-10-12 |
2003-03-20 |
Cell Therapeutics, Inc. |
Manufacture of polyglutamate-therapeutic agent conjugates
|
US20020045220A1
(en)
|
1999-10-13 |
2002-04-18 |
Chaitan Khosla |
Biosynthesis of polyketide synthase substrates
|
CN1086389C
(zh)
*
|
1999-11-12 |
2002-06-19 |
中国科学院上海有机化学研究所 |
异埃坡霉素及合成方法
|
US20030036177A1
(en)
|
2002-08-13 |
2003-02-20 |
Joachim Strohhacker |
Single colonies of myxobacteria cells
|
WO2001064650A2
(en)
|
2000-03-01 |
2001-09-07 |
Sloan-Kettering Institute For Cancer Research Center |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
US6518421B1
(en)
|
2000-03-20 |
2003-02-11 |
Bristol-Myers Squibb Company |
Process for the preparation of epothilone analogs
|
US6593115B2
(en)
|
2000-03-24 |
2003-07-15 |
Bristol-Myers Squibb Co. |
Preparation of epothilone intermediates
|
TWI310684B
(en)
|
2000-03-27 |
2009-06-11 |
Bristol Myers Squibb Co |
Synergistic pharmaceutical kits for treating cancer
|
DE10020517A1
(de)
|
2000-04-19 |
2001-10-25 |
Schering Ag |
Neue Epothilon-Derivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
|
DE10020899A1
(de)
|
2000-04-20 |
2001-10-25 |
Schering Ag |
9-Oxa-Epothilon-Derivate, Verfahren zu deren Herstellung sowie ihre Verwendung in pharmazeutischen Präparaten
|
US6489314B1
(en)
|
2001-04-03 |
2002-12-03 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
US6998256B2
(en)
|
2000-04-28 |
2006-02-14 |
Kosan Biosciences, Inc. |
Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
WO2001083803A1
(en)
|
2000-05-02 |
2001-11-08 |
Kosan Biosciences, Inc. |
Overproduction hosts for biosynthesis of polyketides
|
US20020045609A1
(en)
|
2000-05-26 |
2002-04-18 |
Gary Ashley |
Epothilone derivatives and methods for making and using the same
|
WO2002008440A2
(en)
|
2000-07-25 |
2002-01-31 |
Kosan Biosciences, Inc. |
Fermentation process for epothilones
|
AU2001283275A1
(en)
|
2000-08-09 |
2002-02-18 |
Kosan Biosciences, Inc. |
Bio-intermediates for use in the chemical synthesis of polyketides
|
UA75365C2
(en)
|
2000-08-16 |
2006-04-17 |
Bristol Myers Squibb Co |
Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
|
AU8494601A
(en)
*
|
2000-08-18 |
2002-03-04 |
Univ Illinois |
Prodrugs of betulinic acid derivatives for the treatment of cancer and HIV
|
US7766956B2
(en)
|
2000-09-22 |
2010-08-03 |
Boston Scientific Scimed, Inc. |
Intravascular stent and assembly
|
AU2002213248A1
(en)
|
2000-10-13 |
2002-04-22 |
The University Of Mississipi |
Synthesis of epothilones and relates analogs
|
DE10051136A1
(de)
|
2000-10-16 |
2002-04-18 |
Ludger A Wessjohann |
Epothilone-Synthesebausteine III und Verfahren zur Herstellung von Epothilon B, D und Epothilonderivaten
|
WO2002032844A2
(de)
|
2000-10-16 |
2002-04-25 |
Morphochem Ag |
Epothilone-synthesebausteine iii und iv: unsymmetrisch substituierte acyloine und acyloinderivate, verfahren zu deren herstellung sowie verfahren zur herstellung von epothilon b, d und epothilonderivaten
|
CA2428425A1
(en)
|
2000-11-07 |
2002-08-01 |
Dana-Farber Cancer Institute, Inc. |
Method of treating hematologic tumors and cancers
|
US7070797B2
(en)
|
2000-11-07 |
2006-07-04 |
Dana Farber Cancer Institute, Inc. |
Method of treating hematologic tumors and cancers
|
EP1363996A2
(en)
|
2000-11-22 |
2003-11-26 |
Novartis AG |
Epothilone resistant cell lines
|
GB0029895D0
(en)
*
|
2000-12-07 |
2001-01-24 |
Novartis Ag |
Organic compounds
|
JP2004521122A
(ja)
|
2001-01-25 |
2004-07-15 |
ブリストル−マイヤーズ スクイブ カンパニー |
エポチロン類似体の非経口製剤
|
NZ526871A
(en)
|
2001-01-25 |
2006-01-27 |
Bristol Myers Squibb Co |
Pharmaceutical dosage forms of epothilones for oral administration
|
HU229349B1
(en)
|
2001-01-25 |
2013-11-28 |
Bristol Myers Squibb Co |
Methods for preparation of pharmaceutical composition containing epothilone analogs useful for treatment of cancer
|
US20030004338A1
(en)
|
2001-02-01 |
2003-01-02 |
Li Wen Sen |
Process for the preparation of epothilone analogs
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
EE200300396A
(et)
|
2001-02-20 |
2003-12-15 |
Bristol-Myers Squibb Company |
Epotilooni derivaatide kasutamine refraktaarsete kasvajate raviks
|
CA2438598A1
(en)
|
2001-02-20 |
2002-08-29 |
Francis Y. F. Lee |
Epothilone derivatives for the treatment of refractory tumors
|
NZ527557A
(en)
|
2001-02-27 |
2005-05-27 |
Biotechnolog Forschung Gmbh |
Degradation of epothilones and ethynyl substituted epothilones
|
RU2313345C2
(ru)
|
2001-02-27 |
2007-12-27 |
Новартис Аг |
Комбинации, содержащие ингибитор трансдукции сигнала и производное эпотилона
|
CZ305799B6
(cs)
|
2001-03-14 |
2016-03-23 |
Bristol-Myers Squibb Company |
Kombinace analogů epothilonu a chemoterapeutických činidel pro léčení proliferačních nemocí
|
US7030147B2
(en)
|
2001-03-19 |
2006-04-18 |
Novartis Ag |
Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
|
US20020169125A1
(en)
|
2001-03-21 |
2002-11-14 |
Cell Therapeutics, Inc. |
Recombinant production of polyanionic polymers and uses thereof
|
JP2004528309A
(ja)
|
2001-03-23 |
2004-09-16 |
ナプロ バイオセラピューティクス,インコーポレイテッド |
癌治療用分子複合体
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
US6900214B2
(en)
|
2001-03-29 |
2005-05-31 |
Bristol-Myers Squibb Company |
Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
|
US20020197261A1
(en)
|
2001-04-26 |
2002-12-26 |
Chun Li |
Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
|
US6906188B2
(en)
|
2001-04-30 |
2005-06-14 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Method for synthesizing epothilones and epothilone analogs
|
US20030023082A1
(en)
|
2001-05-15 |
2003-01-30 |
Gary Ashley |
Epothilone derivatives and methods for making and using the same
|
EP1392664A4
(en)
|
2001-06-01 |
2005-01-26 |
Bristol Myers Squibb Co |
EPOTHILONE DERIVATIVES
|
CN1543356B
(zh)
|
2001-06-25 |
2011-09-28 |
味之素株式会社 |
抗肿瘤剂
|
US6933385B2
(en)
|
2001-08-03 |
2005-08-23 |
Schering Ag |
Protected 3,5-dihydroxy-2,2-dimethyl-valeroamides for the synthesis of epothilones and derivatives and process for the production and the use
|
DE10138347A1
(de)
|
2001-08-03 |
2003-02-27 |
Schering Ag |
Geschützte 3,5-Dihydroxy-2,2-dimethyl-valeronitrile für die Synthese von Epothilonen- und Derivaten und Verfahren zur Herstellung
|
US6872715B2
(en)
|
2001-08-06 |
2005-03-29 |
Kosan Biosciences, Inc. |
Benzoquinone ansamycins
|
CN100536841C
(zh)
|
2001-08-23 |
2009-09-09 |
诺瓦提斯公司 |
环丙基和环丁基埃坡霉素类似物
|
JP2005504065A
(ja)
|
2001-08-31 |
2005-02-10 |
ブリストル−マイヤーズ スクイブ カンパニー |
癌治療のための組成物および方法
|
BR0212378A
(pt)
|
2001-09-06 |
2004-10-19 |
Schering Corp |
Inibidores de 17beta-hidroxiesteróide desidrogenase tipo 3 para o tratamento de doenças dependentes de androgênio
|
US20030176368A1
(en)
|
2001-09-06 |
2003-09-18 |
Danishefsky Samuel J. |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
WO2003029195A1
(fr)
|
2001-09-28 |
2003-04-10 |
Sumika Fine Chemicals Co., Ltd. |
Intermediaires pour l'elaboration d'un derive de l'epothilone, et leur procede de production
|
TW200300350A
(en)
|
2001-11-14 |
2003-06-01 |
Bristol Myers Squibb Co |
C-5 modified indazolylpyrrolotriazines
|
AU2002360430A1
(en)
|
2001-11-26 |
2003-06-10 |
Kosan Biosciences, Inc. |
14-methyl-epothilones
|
CA2468996A1
(en)
|
2001-12-03 |
2003-06-12 |
Schering Corporation |
Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer
|
DE10164592A1
(de)
|
2001-12-21 |
2003-07-03 |
Schering Ag |
C1-C6-Epothilon-Fragmente und Verfahren für die Herstellung von C1-C6-Fragmenten von Epothilonen und deren Derivaten
|
US6884608B2
(en)
|
2001-12-26 |
2005-04-26 |
Bristol-Myers Squibb Company |
Compositions and methods for hydroxylating epothilones
|
TW200303202A
(en)
|
2002-02-15 |
2003-09-01 |
Bristol Myers Squibb Co |
Method of preparation of 21-amino epothilone derivatives
|
US7585491B2
(en)
|
2002-12-13 |
2009-09-08 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
EP1340498A1
(en)
|
2002-03-01 |
2003-09-03 |
Schering Aktiengesellschaft |
Use of epothilones in the treatment of brain diseases associated with proliferative processes
|
US6900331B2
(en)
|
2002-03-01 |
2005-05-31 |
University Of Notre Dame |
Derivatives of epothilone B and D and synthesis thereof
|
AU2003216491A1
(en)
|
2002-03-07 |
2003-09-22 |
The Board Of Trustees Of The University Of Illinois |
Microtubule stabilizing compounds
|
AU2003218107A1
(en)
|
2002-03-12 |
2003-09-29 |
Bristol-Myers Squibb Company |
C12-cyano epothilone derivatives
|
DE60330651D1
(en)
|
2002-03-12 |
2010-02-04 |
Bristol Myers Squibb Co |
C3-cyanoepothilonderivate
|
US6900208B2
(en)
|
2002-03-28 |
2005-05-31 |
Bristol Myers Squibb Company |
Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
|
TW200400191A
(en)
|
2002-05-15 |
2004-01-01 |
Bristol Myers Squibb Co |
Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives
|
WO2004103267A2
(en)
|
2002-05-20 |
2004-12-02 |
Kosan Biosciences, Inc. |
Methods to administer epothilone d
|
US7008936B2
(en)
|
2002-06-14 |
2006-03-07 |
Bristol-Myers Squibb Company |
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
|
TW200401638A
(en)
|
2002-06-20 |
2004-02-01 |
Bristol Myers Squibb Co |
Heterocyclic inhibitors of kinases
|
DE10232094A1
(de)
|
2002-07-15 |
2004-02-05 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
5-Thiaepothilone und 15-disubstituierte Epothilone
|
TWI329112B
(en)
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
JP2006505627A
(ja)
|
2002-07-31 |
2006-02-16 |
シエーリング アクチエンゲゼルシャフト |
新規エフェクター接合体、それらの生成方法及びそれらの医薬使用
|
WO2004014919A1
(en)
|
2002-08-02 |
2004-02-19 |
Novartis Ag |
Epothilone derivatives
|
WO2004013145A1
(en)
|
2002-08-02 |
2004-02-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
AU2003260723A1
(en)
|
2002-08-17 |
2004-03-03 |
The Queens Universlty Of Belfast |
Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimer
|
US20040126379A1
(en)
|
2002-08-21 |
2004-07-01 |
Boehringer Ingelheim International Gmbh |
Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agents
|
EP1391213A1
(en)
|
2002-08-21 |
2004-02-25 |
Boehringer Ingelheim International GmbH |
Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents
|
US20040247620A1
(en)
|
2002-08-21 |
2004-12-09 |
Kosan Biosciences, Inc. |
Transformation system based on the integrase gene and attachment site for Myxococcus xanthus bacteriophage Mx9
|
WO2004017943A2
(en)
|
2002-08-23 |
2004-03-04 |
Medigene Oncology Gmbh |
Non-vesicular cationic lipid formulations
|
US6921769B2
(en)
|
2002-08-23 |
2005-07-26 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
EP1506203B1
(en)
*
|
2002-08-23 |
2007-01-03 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto, analogues and uses thereof
|
US7649006B2
(en)
|
2002-08-23 |
2010-01-19 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of epothilones, intermediates thereto and analogues thereof
|
CA2497450C
(en)
|
2002-09-04 |
2011-05-31 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
AU2003298571B2
(en)
|
2002-09-04 |
2006-10-19 |
Merck Sharp & Dohme Corp. |
Pyrazolo[1,5-a]pyrimidines compounds as cyclin dependent kinase inhibitors
|
TW200413377A
(en)
|
2002-09-04 |
2004-08-01 |
Schering Corp |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
CA2497539A1
(en)
|
2002-09-04 |
2004-03-18 |
Schering Corporation |
Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
US20040043089A1
(en)
|
2002-09-04 |
2004-03-04 |
Rabie A-Bakr M |
Buguzhi agent and composition and methods of preparing and administering the same
|
GB0221312D0
(en)
|
2002-09-13 |
2002-10-23 |
Novartis Ag |
Organic compounds
|
CA2499145A1
(en)
|
2002-09-16 |
2004-03-25 |
Agcert International, Llc |
Food-borne pathogen and spoilage detection device and method
|
KR20050052500A
(ko)
|
2002-09-19 |
2005-06-02 |
쉐링 코포레이션 |
사이클린 의존성 키나제 억제제로서의 이미다조피리딘
|
MXPA05003059A
(es)
|
2002-09-19 |
2005-05-27 |
Schering Corp |
Pirazolopiridinas como inhibidores de cinasa dependientes de ciclina.
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
KR101406635B1
(ko)
|
2002-09-23 |
2014-06-11 |
브리스톨-마이어스 스큅 컴퍼니 |
에포틸론 b의 제조, 분리 및 정제 방법, 및 에포틸론 b의 x-선 결정 구조
|
TW200412967A
(en)
|
2002-09-23 |
2004-08-01 |
Schering Corp |
Novel imidazopyrazines as cyclin dependent kinase inhibitors
|
KR20050057520A
(ko)
|
2002-09-23 |
2005-06-16 |
쉐링 코포레이션 |
사이클린 의존성 키나제 억제제로서의 이미다조피라진
|
US20040058899A1
(en)
|
2002-09-25 |
2004-03-25 |
Klimko Peter G. |
Use of epothilones and analogs in conjunction with ophthalmic surgery
|
WO2004030620A2
(en)
|
2002-09-30 |
2004-04-15 |
Bristol-Myers Squibb Company |
Novel tyrosine kinase inhibitors
|
TW200501960A
(en)
|
2002-10-02 |
2005-01-16 |
Bristol Myers Squibb Co |
Synergistic kits and compositions for treating cancer
|
KR20050051688A
(ko)
|
2002-10-09 |
2005-06-01 |
코산 바이오사이언시즈, 인코포레이티드 |
에포틸론(Еpo) D + 5-플루오로우라실(FU)/겜시타빈
|
WO2004032866A2
(en)
|
2002-10-09 |
2004-04-22 |
Kosan Biosciences, Inc. |
Therapeutic formulations
|
BR0314555A
(pt)
|
2002-10-11 |
2005-08-09 |
Dana Farber Cancer Inst Inc |
Derivados de epotilona para o tratamento de mieloma múltiplo
|
AU2003267751A1
(en)
|
2002-10-15 |
2004-05-04 |
Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College |
Use of epothilone derivatives for the treatment of hyperparathyroidism
|
EP1585504A4
(en)
|
2002-11-06 |
2009-07-15 |
Azaya Therapeutics Inc |
LIPOSOMAL PREPARATIONS OF PHARMACEUTICAL AGENTS STABILIZED BY PROTEINS
|
EP1562941B1
(en)
|
2002-11-07 |
2009-12-23 |
Kosan Biosciences, Inc. |
Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
|
BR0315537A
(pt)
|
2002-11-14 |
2005-09-27 |
Celmed Oncology Usa Inc |
Pró-drogas ativadas por peptìdeo desformilase
|
AU2003296242A1
(en)
|
2002-11-28 |
2004-06-18 |
Wolfgang Richter |
Thia-epothilone derivatives for the treatment of cancer
|
AU2003291872A1
(en)
|
2002-12-04 |
2004-06-23 |
Inrs (Institut National De Recherche Scientifique) |
An exopolysaccharides delivery system for active molecules
|
DE10256982A1
(de)
|
2002-12-05 |
2004-06-24 |
Schering Ag |
Neue Effektor-Konjugate, Verfahren zu Ihrer Herstellung und Ihre Pharmazeutische Verwendung
|
JP2006510626A
(ja)
|
2002-12-05 |
2006-03-30 |
シエーリング アクチエンゲゼルシャフト |
増殖疾患の処理における部位特異的供給のためのエポチロン類似体
|
BR0317150A
(pt)
|
2002-12-09 |
2005-11-01 |
Novartis Ag |
Estabilizadores de microtúbulos em stents para o tratamento de estenose
|
WO2004052237A2
(en)
|
2002-12-09 |
2004-06-24 |
Medtronic Vascular |
Modular stent having polymer bridges at modular unit contact sites
|
PT1585548T
(pt)
|
2002-12-09 |
2018-10-17 |
Abraxis Bioscience Llc |
Composições e métodos de administração de agentes farmacológicos
|
EP1581261A4
(en)
|
2002-12-12 |
2009-10-21 |
Conforma Therapeutics Corp |
CYTOTOXINS AND DIAGNOSTIC IMAGING AGENTS COMPRISING HSP90 LIGANDS
|
TW200420565A
(en)
|
2002-12-13 |
2004-10-16 |
Bristol Myers Squibb Co |
C-6 modified indazolylpyrrolotriazines
|
GB0230024D0
(en)
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
US7189716B2
(en)
|
2003-01-03 |
2007-03-13 |
Bristol-Myers Squibb Company |
Tyrosine kinase inhibitors
|
WO2004078978A1
(en)
|
2003-02-26 |
2004-09-16 |
Bristol-Myers Squibb Company |
Compositions and methods for hydroxylating epothilones
|
GB0305928D0
(en)
|
2003-03-14 |
2003-04-23 |
Novartis Ag |
Organic compounds
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
JP2006523235A
(ja)
|
2003-03-28 |
2006-10-12 |
コーザン バイオサイエンシス インコーポレイテッド |
再狭窄を予防するための装置、方法及び組成物
|